Forensic drug testing laboratory accreditation is an outside review of a laboratory that tests specimens for drugs of abuse for non-medical purposes, such as employment screening and law enforcement; the College of American Pathologists (CAP) runs a dedicated Forensic Drug Testing Accreditation Program. This page is for laboratories seeking that accreditation, expanding their testing, or fixing their records and quality system, including labs that also work under the federal workplace testing guidelines. Integral Healthcare Solutions (IHS) drafts the custody, reporting and records procedures for forensic drug testing accreditation; your scientists own testing validity.
Last reviewed: October 2026.
What is forensic drug testing accreditation?
CAP's Forensic Drug Testing Standards for Accreditation treat testing as forensic when it serves non-medical purposes, such as employment screening or law enforcement. The testing covers drugs of abuse and alcohol (CAP FDT Standards for Accreditation, document opened October 3, 2026). CAP's program page presents the program as one that gives laboratories assurance about their results (CAP Forensic Drug Testing Accreditation Program, as read October 2, 2026).
The documents CAP names for the program are the Standards for Accreditation and the checklists you purchase (Forensic Drug Testing, Chemistry and Toxicology, Laboratory General, Director Assessment and All Common). The edition of the Standards we reviewed carries a June 2018 revision date. CAP's program page names no edition and refers to annually updated checklists, so confirm with CAP which edition applies. In that edition, Standard III (Quality Management) lists chain-of-custody documentation, test system validation and analytic quality control among the areas where the laboratory needs written policies and procedures (CAP FDT Standards, document opened October 3, 2026).
On scope, as we read CAP's program page on October 2, 2026, the specimen list runs beyond urine, oral fluid and hair to nails, meconium, umbilical cord and whole blood, with forensic and clinical testing both in view. The same page describes a 2025 change that brings clinical toxicology run by forensic toxicology laboratories into the program, with CLIA compliance for that testing certified by CAP (CAP). The 2018 Standards place non-forensic testing outside the program. The current program page describes the 2025 change, and this page follows the program page.
On inspection rhythm, as we read the program page on October 2, 2026, CAP inspects on site every two years against its accreditation checklists, and the laboratory performs its own self-inspection in the year between (CAP).
Federally regulated workplace testing runs under a second text: the HHS Mandatory Guidelines for Federal Workplace Drug Testing Programs using Urine (88 FR 70768, effective February 1, 2024) and using Oral Fluid (88 FR 70814, effective October 10, 2023), with laboratory certification through SAMHSA's National Laboratory Certification Program (NLCP). In March 2026, HHS stated that it "has made no revisions to the current drug testing panels for both urine and oral fluid and current required nomenclature for laboratory and Medical Review Officer Reports, effective July 7, 2025" (Federal Register 2026-04981).
Who needs it and what triggers it
The buyer is a laboratory running forensic drug testing services. Common triggers:
- Seeking CAP FDT accreditation for the first time, or adding clinical toxicology under the 2025 scope (CAP).
- Expanding into federally regulated testing. SAMHSA states: "In addition to the federal agencies that use HHS-certified laboratories to test specimens for their workplace drug testing programs, the Department of Transportation, the Department of Energy, and the Nuclear Regulatory Commission require the industries they regulate to use HHS-certified laboratories for their workplace drug testing programs" (SAMHSA NLCP).
- Remediating custody, records or quality-system findings before the next biennial inspection or self-inspection.
CLIA treats forensic work differently. Its rules do not apply to "Any facility or component of a facility that only performs testing for forensic purposes" or to "Laboratories certified by the Substance Abuse and Mental Health Services Administration (SAMHSA), in which drug testing is performed which meets SAMHSA guidelines and regulations. However, all other testing conducted by a SAMHSA-certified laboratory is subject to this rule" (42 CFR 493.3(b)).
How IHS helps
IHS markets a process, applied to the CAP FDT checklist set your laboratory holds:
- Gap assessment against the CAP FDT Standards and checklists.
- Questionnaires on chain of custody, qualifications, exception handling and reporting.
- Document and evidence mapping: a crosswalk from each checklist requirement to the audit evidence that shows it is met. Where the laboratory also seeks HHS certification, the same documents are mapped to the Mandatory Guidelines it operates under.
- Drafting custody, exception-handling, reporting and records procedures for your laboratory director to review and approve.
- Mock document audit before the inspection.
- Readiness support through inspection and the deficiency response.
What you supply: the checklists, your SOPs, custody forms, and your qualified scientists and medical review officers.
The limit: testing validity and result interpretation are scientific and medical-review judgments that stay with your laboratory. Collection-site operations are a separate scope. Your laboratory applies to CAP or SAMHSA and hosts every inspection; IHS does not apply on your behalf.
What to have ready
- Your purchased CAP checklists: Forensic Drug Testing, Chemistry and Toxicology, Laboratory General, Director Assessment and All Common, with editions noted.
- The edition of the CAP FDT Standards for Accreditation CAP gives you (the edition we reviewed was revised June 2018).
- Your chain-of-custody procedure and current custody forms, for Standard III's "chain-of-custody documentation" (CAP FDT Standards).
- A list of specimen types and methods, checked against the specimen coverage on CAP's program page: urine, oral fluid, hair, nails, meconium, umbilical cord and whole blood (CAP, as read October 2, 2026).
- A decision on whether clinical toxicology is in scope, given the 2025 change under which CAP certifies that testing for CLIA compliance (CAP, as read October 2, 2026).
- Your exception-handling and result-reporting procedures, with recent examples.
- A plan for the self-inspection in the off-year between on-site inspections (CAP, as read October 2, 2026).
- If you serve federal, DOT, DOE or NRC testing: the Mandatory Guidelines version you operate under, and the NLCP proficiency testing and inspection schedule (SAMHSA NLCP).
- An owner for the deficiency response: CAP's accreditation process page gives laboratories 30 days to respond to deficiencies (CAP accreditation process, page opened October 3, 2026).
Printable version of this checklist (PDF)
How it compares
The routes below come from the sources' own pages. Which apply depends on who your clients are and what testing you run; some laboratories hold more than one.
| Route | What the sources say |
|---|---|
| CAP Forensic Drug Testing Accreditation Program | On-site inspection every two years plus an off-year self-inspection; forensic testing and, since 2025, clinical toxicology (CAP). |
| HHS certification through SAMHSA's NLCP | Used by federal agencies, and required by DOT, DOE and NRC for the industries they regulate. Certification takes "three rounds of PT and an inspection occurring concurrent with the third set of PT," another inspection three months later, quarterly maintenance PT and "every semiannual maintenance inspection" (SAMHSA NLCP). |
| CAP Laboratory Accreditation Program | The 2018 FDT Standards pointed laboratories seeking accreditation for non-forensic testing to the CAP Laboratory Accreditation Program or other programs (CAP FDT Standards, document opened October 3, 2026). CAP's current FDT page says the program now also accredits clinical toxicology, so check which route fits your testing. See CAP laboratory accreditation. |
| No accreditation | 42 CFR 493.3(b)(1) says CLIA's rules do not apply to "any facility or component of a facility that only performs testing for forensic purposes." CAP's own definition of forensic drug testing includes employment-related screening, and we have not found where CLIA defines "forensic purposes." IHS's reading is not settled on whether a given workplace-testing line falls inside that exclusion. Confirm with your counsel or the CMS/state CLIA agency before relying on it. What your clients and contracts expect is a separate question this page does not answer. |
What it costs
CAP does not publish a fee schedule on the pages we reviewed, and fees depend on scope. CAP's accreditation process page offers a fee estimate form for laboratories that want cost and next-step information, and says the application fee is waived when a laboratory buys the checklists and applies within six months (CAP accreditation process, page opened October 3, 2026). SAMHSA says NLCP fees "are posted on this website" (SAMHSA NLCP). We have not quoted an amount here. Verify current fees with CAP and SAMHSA. IHS scopes each engagement after a free introductory call.
What this is not
- IHS is not CAP, SAMHSA or HHS and does not grant, predict or influence an accreditation or certification decision.
- IHS does not contact, apply to or speak for your laboratory to CAP or SAMHSA. IHS drafts; your laboratory applies and hosts every inspection.
- IHS does not judge testing validity, interpret results or act as a medical review officer, and this page is not legal advice.
Frequently asked questions
What is CAP forensic drug testing accreditation?
It is CAP's accreditation program for laboratories whose testing serves non-medical purposes such as employment screening and law enforcement, covering drugs of abuse and alcohol. As of our October 2, 2026 read of the program page, CAP inspects on site every two years against its checklists, and the laboratory self-inspects in between.
What is the difference between CAP FDT accreditation and SAMHSA/HHS certification?
CAP FDT accreditation is CAP's program, inspected against the CAP FDT Standards and checklists. HHS certification runs through SAMHSA's National Laboratory Certification Program under the Mandatory Guidelines, with three rounds of proficiency testing, an inspection with the third round, another inspection three months after certification, quarterly maintenance PT and semiannual maintenance inspections.
Which drug testing programs require an HHS-certified laboratory?
SAMHSA states that federal agencies use HHS-certified laboratories for their workplace drug testing programs, and that the Department of Transportation, the Department of Energy and the Nuclear Regulatory Commission require the industries they regulate to use HHS-certified laboratories.
Does a forensic toxicology lab need a CLIA certificate?
CLIA's rules at 42 CFR 493.3(b) do not apply to a facility or component that only performs testing for forensic purposes, or to SAMHSA-certified drug testing that meets SAMHSA guidelines. Whether your workplace-testing line counts as testing only for forensic purposes is not something this page decides. All other testing at a SAMHSA-certified laboratory is subject to CLIA, so a lab that also does clinical testing needs to look at that testing separately.
Can CAP FDT accreditation cover clinical toxicology testing too?
Yes, since 2025. As of our October 2, 2026 read of the program page, the program now takes in clinical toxicology that forensic toxicology laboratories perform, and CAP certifies that testing for CLIA compliance.
Which specimen types does CAP FDT accreditation cover?
As of our October 2, 2026 read of the program page, the specimen list runs beyond urine, oral fluid and hair to nails, meconium, umbilical cord and whole blood, with forensic and clinical testing both in view.
How often are CAP FDT laboratories inspected?
CAP inspects on site every two years against its accreditation checklists, and the laboratory does its own self-inspection in the year between, according to the program page as we read it on October 2, 2026. CAP's accreditation process page gives laboratories 30 days to respond to deficiencies (page opened October 3, 2026).
What chain-of-custody documentation do inspectors expect?
In the 2018 edition of the CAP FDT Standards that we reviewed, Standard III (Quality Management) lists chain-of-custody documentation among the areas needing written policies and procedures. Confirm against the edition CAP currently applies. The detailed requirements sit in the checklists you purchase, which is why IHS works from your copy.
How much does forensic drug testing accreditation cost?
CAP does not publish its fees on the pages we reviewed and offers a fee estimate form. Its accreditation process page says the application fee is waived when a laboratory buys the checklists and applies within six months (page opened October 3, 2026). SAMHSA says NLCP fees are posted on its website. Verify current fees with CAP and SAMHSA. IHS scopes its own work after a free introductory call.
Does IHS handle collection sites or medical review?
No. Collection-site operations are a separate scope, and result interpretation stays with your scientists and medical review officers. IHS drafts laboratory custody, exception, reporting and records procedures for your director to approve.
